Cited 0 times in
Comparison of cilostazol and clopidogrel after successful coronary stenting.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, SW | - |
dc.contributor.author | Park, SW | - |
dc.contributor.author | Hong, MK | - |
dc.contributor.author | Lee, CW | - |
dc.contributor.author | Kim, YH | - |
dc.contributor.author | Park, JH | - |
dc.contributor.author | Kang, SJ | - |
dc.contributor.author | Han, KH | - |
dc.contributor.author | Kim, JJ | - |
dc.contributor.author | Park, SJ | - |
dc.date.accessioned | 2011-06-21T04:32:39Z | - |
dc.date.available | 2011-06-21T04:32:39Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0002-9149 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/2982 | - |
dc.description.abstract | This study compared the safety and efficacy of cilostazol and clopidogrel after coronary stenting. Patients (n = 689) who underwent successful stenting were randomly assigned to receive cilostazol (group 1, n = 344, 612 lesions) or clopidogrel (group 2, n = 345, 628 lesions). The incidence of subacute stent thrombosis or major adverse cardiac events, including death, myocardial infarction, and target lesion revascularization within 30 days (2.6% in group 1 vs 2.0% in group 2, p = 0.61) and side effects that required cessation of study drug (0.6% each) did not differ statistically between groups. These results indicate that cilostazol is as safe and effective as clopidogrel in preventing thrombotic complications after stenting. | - |
dc.language.iso | en | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Angioplasty, Balloon, Coronary | - |
dc.subject.MESH | Aspirin | - |
dc.subject.MESH | Coronary Restenosis | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Myocardial Infarction | - |
dc.subject.MESH | Platelet Aggregation Inhibitors | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Stents | - |
dc.subject.MESH | Tetrazoles | - |
dc.subject.MESH | Thrombosis | - |
dc.subject.MESH | Ticlopidine | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Comparison of cilostazol and clopidogrel after successful coronary stenting. | - |
dc.type | Article | - |
dc.identifier.pmid | 15781016 | - |
dc.identifier.url | http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(05)00010-X | - |
dc.contributor.affiliatedAuthor | 강, 수진 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1016/j.amjcard.2004.12.012 | - |
dc.citation.title | The American journal of cardiology | - |
dc.citation.volume | 95 | - |
dc.citation.number | 7 | - |
dc.citation.date | 2005 | - |
dc.citation.startPage | 859 | - |
dc.citation.endPage | 862 | - |
dc.identifier.bibliographicCitation | The American journal of cardiology, 95(7). : 859-862, 2005 | - |
dc.identifier.eissn | 1879-1913 | - |
dc.relation.journalid | J000029149 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.